Brief: Adagio Medical Announces Positive Pivotal Results For vCLAS Ventricular Ablation System
26/04/2026 14:37
April 26 (Reuters) - Adagio Medical Holdings Inc ADGM.O: ADAGIO MEDICAL ANNOUNCES POSITIVE PIVOTAL RESULTS FOR VCLAS® VENTRICULAR ABLATION SYSTEM ADAGIO MEDICAL- 84% FREEDOM FROM SHOCK AND 59% FREEDOM FROM VT RECURRENCE IN FULCRUM-VT PIVOTAL IDE TRIAL MEET SAFETY AND EFFECTIVENESS ENDPOINTS ADAGIO MEDICAL HOLDINGS INC - FULCRUM-VT TRIAL SHOWS 98% NON-INDUCIBILITY OF TARGETED VT AT END OF PROCEDURE Source text: ID:nBw99Tqwsa Further company coverage: ADGM.O ((Reuters.briefs@thomsonreuters.com;))
Recent news on Adagio Medical Holdings
See all newsBrief: Adagio Medical Submits Premarket Approval Application To FDA For Vclas® Ventricular Ablation System
Brief: Adagio Medical Announces Positive Pivotal Results For vCLAS Ventricular Ablation System
U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines
U.S. STOCKS ON THE MOVE-Meta, Legence, Chegg
Adagio Medical rises after FDA clears expanded testing of heart device